Literature DB >> 2974832

Functional studies on macrophage populations in the airways and the lung wall of SPF mice in the steady-state and during respiratory virus infection.

N Bilyk1, J S Mackenzie, J M Papadimitriou, P G Holt.   

Abstract

Collagenase digestion of slices of lavaged and perfused murine lung from SPF animals yielded, on average, 104 x 10(6) mononuclear cells per gram tissue, including approximately 14% F4/80+ macrophages and 35% lymphocytes. The lung tissue-associated (digest) macrophage (LDM) population was 10-fold higher in number than the alveolar macrophage (AM) population recoverable by lavage. Comparative functional analysis of these populations was performed, employing assays for immune receptors (Fc and C3), complement-induced spreading, endogenous peroxidase, IL-1 secretion and tumour cytolysis; resident and activated peritoneal macrophages and blood monocytes were examined in parallel. The resident LDM population exhibited an activation status intermediate between blood monocytes and the relatively more activated AM from the airways. Murine lung macrophages were also examined during an acute influenza infection and LDM and AM recoveries increased significantly. The AM population exhibited activation during an acute infection. In contrast, LDM remained quiescent, despite the influx of a large number of T lymphocytes into the lung wall. These results suggest that LDM may be intrinsically resistant to the signals generated during T-cell-mediated eradication of influenza, or else local tissue factors modulate T-cell-derived activation signals.

Entities:  

Mesh:

Year:  1988        PMID: 2974832      PMCID: PMC1385481     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  34 in total

1.  Pulmonary cell responses to inhaled cigarette smoke.

Authors:  R Rylander
Journal:  Arch Environ Health       Date:  1974-12

2.  Origin and kinetics of pulmonary macrophages during an inflammatory reaction induced by intra-alveolar administration of aerosolized heat-killed BCG.

Authors:  A Blussé van Oud Alblas; B van der Linden-Schrever; R Van Furth
Journal:  Am Rev Respir Dis       Date:  1983-08

3.  The monocyte in cellular immunity.

Authors:  G B Mackaness
Journal:  Semin Hematol       Date:  1970-04       Impact factor: 3.851

4.  Pathways of clearance in mouse lungs exposed to iron oxide aerosols.

Authors:  S P Sorokin; J D Brain
Journal:  Anat Rec       Date:  1975-03

5.  Alveolitis induced by influenza virus.

Authors:  G J Jakab; C L Astry; G A Warr
Journal:  Am Rev Respir Dis       Date:  1983-10

6.  Sequential activation of murine mononuclear phagocytes for tumor cytolysis: differential expression of markers by macrophages in the several stages of development.

Authors:  W J Johnson; P A Marino; R D Schreiber; D O Adams
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

7.  Influenza infections during pregnancy in the mouse.

Authors:  K Williams; J S Mackenzie
Journal:  J Hyg (Lond)       Date:  1977-10

8.  Bidirectional amplification of macrophage-lymphocyte interactions: enhanced lymphocyte activation factor production by activated adherent mouse peritoneal cells.

Authors:  M S Meltzer; J J Oppenheim
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

9.  The induction of macrophage spreading: role of coagulation factors and the complement system.

Authors:  C Bianco; A Eden; Z A Cohn
Journal:  J Exp Med       Date:  1976-12-01       Impact factor: 14.307

10.  Studies of the macrophage complement receptor. Alteration of receptor function upon macrophage activation.

Authors:  C Bianco; F M Griffin; S C Silverstein
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

View more
  14 in total

1.  Regulation of T-cell proliferative responses by cells from solid lung tissue of M. tuberculosis-infected mice.

Authors:  A S Apt; I B Kramnik; A M Moroz
Journal:  Immunology       Date:  1991-06       Impact factor: 7.397

2.  Alveolar macrophages regulate the induction of primary cytotoxic T-lymphocyte responses during influenza virus infection.

Authors:  O L Wijburg; S DiNatale; J Vadolas; N van Rooijen; R A Strugnell
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

3.  Cytokine and chemokine responses of lung exposed to surrogate viral and bacterial infections.

Authors:  Teresa A Liberati; Rita A Trammell; Michelle Randle; Sarah Barrett; Linda A Toth
Journal:  Comp Med       Date:  2013-04       Impact factor: 0.982

4.  The surface phenotypic characterization of lung macrophages in C3H/HeJ mice.

Authors:  N Bilyk; P G Holt
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

5.  Restricted expression of galactose/N-acetylgalactosamine-specific macrophage C-type lectin to connective tissue and to metastatic lesions in mouse lung.

Authors:  Y Imai; Y Akimoto; S Mizuochi; T Kimura; H Hirano; T Irimura
Journal:  Immunology       Date:  1995-12       Impact factor: 7.397

6.  Antigen-presenting cell population dynamics during murine silicosis.

Authors:  Celine A Beamer; Andrij Holian
Journal:  Am J Respir Cell Mol Biol       Date:  2007-07-19       Impact factor: 6.914

7.  Alveolar macrophages from humans and rodents selectively inhibit T-cell proliferation but permit T-cell activation and cytokine secretion.

Authors:  J W Upham; D H Strickland; N Bilyk; B W Robinson; P G Holt
Journal:  Immunology       Date:  1995-01       Impact factor: 7.397

8.  Cytokine modulation of the immunosuppressive phenotype of pulmonary alveolar macrophage populations.

Authors:  N Bilyk; P G Holt
Journal:  Immunology       Date:  1995-10       Impact factor: 7.397

Review 9.  Pulmonary and thoracic macrophage subpopulations and clearance of particles from the lung.

Authors:  B E Lehnert
Journal:  Environ Health Perspect       Date:  1992-07       Impact factor: 9.031

10.  Inhibition of the immunosuppressive activity of resident pulmonary alveolar macrophages by granulocyte/macrophage colony-stimulating factor.

Authors:  N Bilyk; P G Holt
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.